Table 2 Baseline patient characteristics according to the mGA and the oncologists’ classification

From: Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty

   

Modified geriatric assessment

The oncologists classification

   

mGA-frail

mGA-non-frail

Onc-frail

Onc-non-frail

 

N (288)

%

N (140)

%

N (148)

%

P -value

N (104)

%

N (182)

%

P -value

Age, mean (s.d.)

76.9 (5.1)

 

77.5 (5.2)

 

76.2 (5.0)

 

0.032 a

77.2 (5.4)

 

76.6 (5.0)

 

0.346a

Gender

            

 Female

126

44

64

46

62

42

0.513b

43

41

81

45

0.604b

Cancer type

            

 Colorectal

83

29

39

28

44

30

 

18

17

64

35

 

 Lung

59

21

35

25

24

16

 

34

33

25

14

 

 Prostate

56

19

22

16

34

23

0.045 b

25

24

31

17

<0.001 b

 Other gastrointestinal

34

12

19

14

15

10

 

8

8

25

14

 

 Breast

30

10

9

6

21

14

 

6

6

24

13

 

 Other

26

9

16

11

10

7

 

13

13

13

7

 

Stage

            

 Localised

73

25

30

21

43

29

 

12

12

61

34

 

 Locally advanced

55

19

23

16

32

22

0.091b

22

21

32

18

<0.001 b

 Distant metastasis

160

56

87

62

73

49

 

70

67

89

49

 

ECOG PS

            

 0–1

244

85

106

76

138

93

 

62

60

181

100

 

 2–4

43

15

33

24

10

7

<0.001 b

42

40

0

 

<0.001 b

 Missing

1

 

1

    

0

 

1

  

Treatment

            

 Curativec

91

32

31

22

60

41

 

14

14

77

42

 

 Palliative chemotherapy

126

44

75

54

51

35

 

60

58

66

36

 

 Other palliative systemic cancer treatment

51

18

22

16

29

20

0.002 b

21

20

30

17

<0.001 b

 Non-systemic palliative treatmentd

20

7

12

9

8

5

 

9

9

9

5

 
  1. aIndependent samples t-test.
  2. bPearson χ2-test.
  3. cReferred for neoadjuvant treatment, adjuvant treatment after curative surgery or curative radiotherapy.
  4. dRadiotherapy, palliative surgery or palliative care.
  5. Bold numbers are statistically significant.